Bd, certest biotec announce emergency use authorization for mpox diagnostic test

Assay for research and clinical use now globally available for the bd max™ system franklin lakes, n.j. , jan. 9, 2023 /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, and certest biotec have announced emergency use authorization (eua) from the u.s. food and drug administration (fda) for a molecular polymerase chain reaction (pcr) assay for mpox virus detection.
BDX Ratings Summary
BDX Quant Ranking